Wall St ends higher on vaccine bets, Goldman results


By Noel Randewich

July 15 (Reuters) - U.S. stocks ended higher on Wednesday, following promising early data for a potential COVID-19 vaccine and a strong quarterly report from Goldman Sachs.

Moderna Inc O> rallied after a small-scale study showed its experimental COVID-19 vaccine produced high levels of virus-killing antibodies.

Travel-related stocks Carnival Corp CCL.N, Royal Caribbean Cruises Ltd RCL.N, Marriott International MAR.O and Wynn Resorts > surged, as did the S&P 1500 airlines index .SPCOMAIR.

The S&P 500 beat the technology-heavy Nasdaq Composite for a fourth straight session, a feat scored only twice since Wall Street launched its massive recovery last March.

Gains for the Nasdaq were capped by online retail giant Inc AMZN.O, video streaming platform Netflix Inc NFLX.O and Microsoft Corp MSFT.O, which slipped after surging to record highs recently.

"The Moderna news woke everybody up again that this is not going to last forever, and there is light at the end of the tunnel. That is why you are seeing such a strong move today into those economically sensitive stocks," said Tim Ghriskey, Chief Investment Strategist Inverness Counsel in New York.

Adding to investors' enthusiasm, the Federal Reserve's Beige Book survey showed U.S. businesses saw an uptick in activity into the beginning of July as states eased restrictions to contain the novel coronavirus pandemic.

A raft of stimulus measures and encouraging economic data have lifted the S&P 500 to about 5% below its record high hit in February.

However, the United States has failed to control the coronavirus and there is a high level of uncertainty over how much the pandemic will affect the economy, Philadelphia Federal Reserve Bank President Patrick Harker said, as a number of U.S. sunbelt states reported a surge in COVID-19 cases recently.

Unofficially, the Dow Jones Industrial Average .DJI rose 228.47 points, or 0.86%, to 26,871.06, the S&P 500 .SPX gained 29.1 points, or 0.91%, to 3,226.62 and the Nasdaq Composite .IXIC added 61.92 points, or 0.59%, to 10,550.49.

Goldman Sachs GS.N rose after it said its trading revenue doubled in the second quarter, driven by big swings in stock and bond markets since March.

Morgan Stanley MS.N and Bank of America BAC.N gained ahead of their results on Thursday. The broader banking index .SPXBKalso climbed.

UnitedHealth Group Inc UNH.N fell after warning of rising costs later this year as Americans catch up on less urgent surgeries halted by the coronavirus pandemic.

(Additional reporting by Medha Singh and Devik Jain in Bengaluru Editing by Marguerita Choy )

((; (415) 677 2542; Reuters Messaging: Twitter: @randewich))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.